The impact of mismatch repair status to the preoperative staging of local colon cancer: Implications for clinical management. A 13-gene colorectal cancer liquid biopsy with greater than 90 percent ...
Circulating tumor DNA (ctDNA)-based minimal residual disease (MRD) measured by Guardant Reveal in patients (pts) with HER2-positive (HER2+) metastatic breast cancer (mBC) with long-term disease ...
Gene therapy holds the promise of preventing and curing disease by manipulating gene expression within a patient's cells. However, to be effective, the new gene must make it into a cell's nucleus. The ...
Breast cancer has a survival rate of over 95% when detected early, but this drops sharply to around 40% in cases of metastatic breast cancer, where cancer cells spread to other organs. In the Chosun ...